5ksx
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal structure of human FPPS in complex with an allosteric inhibitor AM-02-072== | ==Crystal structure of human FPPS in complex with an allosteric inhibitor AM-02-072== | ||
- | <StructureSection load='5ksx' size='340' side='right' caption='[[5ksx]], [[Resolution|resolution]] 2.65Å' scene=''> | + | <StructureSection load='5ksx' size='340' side='right'caption='[[5ksx]], [[Resolution|resolution]] 2.65Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5ksx]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5ksx]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KSX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5KSX FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7AM:[[(2~{S})-2-[[6-(4-METHYLPHENYL)THIENO[2,3-D]PYRIMIDIN-4-YL]AMINO]-3-PHENYL-PROPANOYL]AMINO]PHOSPHONIC+ACID'>7AM</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.65Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7AM:[[(2~{S})-2-[[6-(4-METHYLPHENYL)THIENO[2,3-D]PYRIMIDIN-4-YL]AMINO]-3-PHENYL-PROPANOYL]AMINO]PHOSPHONIC+ACID'>7AM</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ksx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ksx OCA], [https://pdbe.org/5ksx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ksx RCSB], [https://www.ebi.ac.uk/pdbsum/5ksx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ksx ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/FPPS_HUMAN FPPS_HUMAN] Key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (FPP), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. FPP also serves as substrate for protein farnesylation and geranylgeranylation. Catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product farnesyl pyrophosphate. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5ksx" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5ksx" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Farnesyl diphosphate synthase 3D structures|Farnesyl diphosphate synthase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Berghuis AM]] |
- | [[Category: | + | [[Category: Matralis A]] |
- | [[Category: | + | [[Category: Park J]] |
- | [[Category: | + | [[Category: Tsantrizos YS]] |
Current revision
Crystal structure of human FPPS in complex with an allosteric inhibitor AM-02-072
|